NIH-funded research U01 cooperative agreement

Improving treatments for organophosphate poisoning

Official title: Optimization of Substituted Phenoxyalkyl Pyridinium Oximes as Therapies for Organophosphate Poisoning

Funded at Mississippi State University · NIH-10906087 · Data updated 2026-11-12

This study is looking for better treatments for people who have been poisoned by certain toxic chemicals, aiming to create a new medicine that can help protect the brain and improve recovery after exposure.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionMississippi State University
NIH-funded
Lab location1 site (Mississippi State, United States)
Project startAugust 1, 2021
Project endJuly 31, 2026
Funding year2024
Award (this year)$657,302
NIH project number5U01NS123255-04
Project IDNIH-10906087 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals who have been exposed to organophosphate compounds, such as those involved in accidents or terrorist attacks.

Less likely to help

Patients who have not been exposed to organophosphate compounds are unlikely to benefit from this research.

What this research studies

This research focuses on developing new therapies for organophosphate poisoning, which can occur from exposure to toxic nerve agents. Current treatments, like atropine and 2-PAM, are not always effective, especially in protecting the brain. The study aims to create a new type of oxime that can better penetrate the blood-brain barrier and improve survival rates and neurological outcomes in affected individuals. The research involves testing these new compounds in animal models to assess their effectiveness and safety.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for organophosphate poisoning, potentially saving lives and preserving brain function.

How similar studies have gone: Previous studies have shown that similar approaches using new oxime compounds have improved outcomes in animal models, indicating potential for success in this research.

Where this research is happening

  • Mississippi State University
    Mississippi State, United States
    Active

Researchers

  • Principal investigator: Chambers, Janice Elaine — Mississippi State University
  • Study coordinator: Chambers, Janice Elaine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.